ARCHIVES

Study Of Tamoxifen And Raloxifene Enrolls 6,000 In First Year; 5 Percent Are Minorities

This article is from The Cancer Letter archive.

Vol. 23 No. 7 | July 28, 2000

Download PDF Visit The Full Archive

Related Articles

ADT Does Not Raise Risk of Heart Attacks In Men With No History Of Heart Disease

November 25, 2011

Consortium Aims To Make Mice Whose Cancers Act Human.

January 7, 2000

St. Jude Offers Three Fellowships

May 3, 1985

Large Phase III Trial Seeks Optimal Use Of Tykerb vs. Herceptin In Breast Cancer

February 29, 2008

NCAB Approves Plan for National Black Leadership Initiative

October 16, 1987

Pacific Yew Act Would Result In Duplications, Delays In Taxol Production, Witnesses Say

March 13, 1992